AMC posted its best admissions revenue week in its 103-year history, driven primarily by 'Barbenheimer.'
Share:
More In Business

From Trade Tensions to Rate Cuts: What’s Driving the Market Now?
Mark Hackett, Chief Market Strategist at Nationwide, shares insight on market sentiment, Fed policy impact, and the outlook amid trade tensions.

Crypto 401(k)s Explained: Maple CEO Sid Powell on the Staking Revolution
Sid Powell, CEO of Maple Finance, demystifies crypto 401(k)s and explains how staking lets users earn passive yield while supporting decentralization.

Bullish IPO Soars: An Inside View with President Chris Tyrer
Chris Tyrer, President at Bullish (NYSE: BLSH), reveals how the IPO-fueled rise of the company is redefining institutional crypto markets.

Inside the Pricey White House Upgrade No One Saw Coming
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.

Spirit Airlines sounds the alarm on its future ability to stay in business
Just five months after emerging from Chapter 11 bankruptcy protection, Spirit Airlines is warning about its future ability to stay in business.

SoCal Police find $30K worth of Labubus stolen from warehouse
A police department in Southern California has recovered about $30,000 worth of Labubus that were stolen from a warehouse.

Why many Americans are rethinking alcohol, according to a new poll
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.

Amazon expands its perishable delivery service, pressuring grocers
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.

Is RFK Jr. Halting Progress? The Fallout of Cutting mRNA Vaccine Research
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
